Interferon beta corrects gene processing disrupted in MS: Study
Alternative splicing, a biological process that allows a single gene to code for multiple proteins, is extensively disrupted in immune cells isolated from untreated multiple sclerosis (MS) patients, and long-term treatment with interferon beta-based therapies largely corrects the defects, a study found. āAlternative splicing is a potential biomarker warning…